Equities

IFR US ECM Calendar

 |  Robert Sherwood

Week of February 23: AGT Food and Ingredients (Canada, food) ─ C$460m TSX IPO (Primary, Secondary). 15.33m-17.69m shares at C$26-$30. NBF, SCOT. TSX “AGTF”. OMERS is the selling shareholder.

February 25: Palvella Therapeutics (US, biotech) ─ $150m FO. Fixed size (Primary) versus $120.41 at launch. TDC, CANT, STFL, MIZU, LSCI, OPCO, CGEN, HCW. Reverse inquiry.

February 25: Vir Biotechnology (US, biotech) ─ $200m FO. Fixed size (Primary) versus $9.49 at launch. GS, LEER, GUGG, BARC.

February 26: Generate Biomedicines (US, biotech) ─ $425m IPO. 25m shares (Primary) at $15-$17. GS, MS, PS, GUGG, CANT. Nasdaq “GENB”.

March 5: MiniMed (US, medical devices) ─ $784m IPO. 28m shares (Primary) at $25-$28. GS, BOFA, CITI, MS. Nasdaq “MMED”. Spin-off from Medtronic.

March 5: Robinhood Ventures Fund I (US, closed end fund) ─ $1bn IPO. 40m shares (Primary, Secondary) at $25.00. GS. Robinhood Markets is selling 5m shares. Marketing extended from scheduled 2/25 pricing.

Topics
Americas North America United States Equity Capital ABBs and Block Trades Initial Public Offerings (IPO) US Dollar Canada Marketed Follow-Ons Structured Equity
Issuers
AGT FOOD AND INGREDIENTS INC Palvella Therapeutics Inc (PVLA.OQ) Vir Biotechnology Inc (VIR.O) Generate Biomedicines Inc MiniMed Group Inc Medtronic PLC (MDT.N) Robinhood Markets Inc (HOOD.O) Robinhood Ventures Fund I (RVI.N)